Tardive Dyskinesia
📧 Sign up to get email alerts when something new happens for Tardive Dyskinesia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia [Phase 4]
Phase 4 study evaluating valbenazine for tardive dyskinesia in participants with schizophrenia, schizoaffective disorder, bipolar disorder, …
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Xenazine in Late Dyskinetic Syndrome With Neuroleptics [Phase 3]
Phase 3 trial update on Xenazine (tetrabenazine) for tardive dyskinesia in patients treated with neuroleptics; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects [Phase 1]
Phase 1 study assessing safety, tolerability and pharmacokinetics of escalating doses of LPM3770164 in healthy subjects, with potential rele…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets [Phase 1]
A Phase 1 clinical trial evaluating the effect of food on the pharmacokinetics of LPM3770164 sustained-release tablets. The study is complet…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluated MT-5199 for efficacy and safety in tardive dyskinesia. Results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia [Phase 4]
Phase 4 trial update on the persistence of effect and safety of valbenazine for tardive dyskinesia.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Reducing Involuntary Movements in Participants With Tardive Dyskinesia [Phase 3]
Phase 3 clinical trial update on reducing involuntary movements in tardive dyskinesia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine [Phase 4]
Phase 4 trial update exploring potential dependence and withdrawal symptoms associated with valbenazine in tardive dyskinesia.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates [Phase 4]
Phase 4 trial evaluating varenicline for smoking cessation in schizophrenia with antipsychotic-induced neurological symptoms as correlates; …
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia [Phase 2]
Phase 2 trial evaluating Pyridoxal 5'-Phosphate for tardive dyskinesia was terminated.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia [Phase 3]
A Phase 3 rollover study evaluating continuing valbenazine (NBI-98854) for tardive dyskinesia has completed and posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia [Phase 3]
Phase 3 safety and tolerability study of NBI-98854 for tardive dyskinesia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Addressing Involuntary Movements in Tardive Dyskinesia [Phase 3]
Phase 3 trial update on addressing involuntary movements in tardive dyskinesia.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Aim to Reduce Movements in Tardive Dyskinesia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update for an attempt to reduce movements in tardive dyskinesia by Auspex Pharmaceuticals; the study is com…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study) [Phase 2]
This entry reports completion of a Phase 2 trial (KINECT) evaluating NBI-98854 for tardive dyskinesia in individuals with schizophrenia or s…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 2]
Phase 2 trial update for NBI-98854 (valbenazine) in tardive dyskinesia in patients with schizophrenia or schizoaffective disorder; results w…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia [Phase 2]
The document reports the completion and posted results of a Phase 2 dose-titration trial of NBI-98854 for tardive dyskinesia.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia [Phase 3]
Phase 3 trial results for NBI-98854 in tardive dyskinesia have been posted following completion of the study.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia [NA]
A clinical trial evaluating deep brain stimulation for tardive dyskinesia and tardive dystonia (NCT02524886) has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: The Assessment of Movement Disorders Utilizing Live Two-Way Video
This clinical trial update reports on assessing movement disorders in tardive dyskinesia using live two-way video and the study has complete…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Melatonin Treatment for Tardive Dyskinesia in Schizophrenia [NA]
This completed clinical trial evaluated melatonin as a treatment for tardive dyskinesia in individuals with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Levetiracetam Treatment of Tardive Dyskinesia [Phase 3]
Phase 3 trial of levetiracetam for tardive dyskinesia completed; sponsor Yale University.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia [Phase 2]
Phase 2 trial evaluating levetiracetam for neuroleptic-induced tardive dyskinesia has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study assessed whether Panax ginseng can enhance the efficacy of antipsychotics in schizophrenia and schizoaffec…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia [Phase 2]
A Phase 2 study assessing the efficacy and safety of NBI-98854 in tardive dyskinesia has been completed.